Proxim Diagnostics

About:

Proxim Diagnostics develops a next generation handheld immuno diagnostic device.

Website: http://www.proximdx.com

Top Investors: bioMerieux

Description:

Proxim Diagnostics develops a next generation handheld immuno diagnostic device. It performs the most important laboratory tests near the patient using whole blood without any sacrifice in sensitivity and precision. Proxim Diagnostics' device can also test blood gases, electrolytes and metabolites, infectious disease antigens and antibodies. Special attention was given to the disposable test cartridge, which can be manufactured at a low cost. Proxim’s unique combination of high performance and low cost not only make it ideal for hospital Emergency Departments in the USA but also in other settings around the world.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2009-01-01

Contact Email:

hello(AT)proximdx.com

Founders:

Mikhail Briman, Vikram Joshi

Number of Employees:

1-10

Last Funding Date:

2023-03-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai